Medifast, Inc.
MED
$12.36
$0.534.48%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -36.29% | -37.62% | -39.47% | -43.80% | -44.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -36.29% | -37.62% | -39.47% | -43.80% | -44.64% |
| Cost of Revenue | -32.98% | -37.39% | -41.14% | -46.71% | -47.72% |
| Gross Profit | -37.47% | -37.70% | -38.85% | -42.69% | -43.45% |
| SG&A Expenses | -35.24% | -34.08% | -29.39% | -32.19% | -32.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -34.39% | -34.78% | -32.71% | -36.60% | -37.14% |
| Operating Income | -152.55% | -98.58% | -107.82% | -97.72% | -93.33% |
| Income Before Tax | -83.61% | -83.23% | -108.35% | -97.06% | -91.87% |
| Income Tax Expenses | -64.50% | -67.13% | -101.43% | -94.23% | -84.16% |
| Earnings from Continuing Operations | -96.61% | -87.60% | -110.32% | -97.90% | -93.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -96.61% | -87.60% | -110.32% | -97.90% | -93.89% |
| EBIT | -152.55% | -98.58% | -107.82% | -97.72% | -93.33% |
| EBITDA | -26.43% | -50.61% | -83.45% | -82.24% | -86.46% |
| EPS Basic | -96.65% | -87.70% | -110.28% | -97.89% | -93.88% |
| Normalized Basic EPS | -83.71% | -83.34% | -108.32% | -97.05% | -92.46% |
| EPS Diluted | -98.57% | -88.07% | -110.50% | -98.02% | -94.02% |
| Normalized Diluted EPS | -83.77% | -83.33% | -108.36% | -97.09% | -92.49% |
| Average Basic Shares Outstanding | 0.44% | 0.42% | 0.41% | 0.42% | 0.27% |
| Average Diluted Shares Outstanding | 0.41% | 0.45% | 0.22% | 0.38% | 0.13% |
| Dividend Per Share | -- | -- | -- | -- | -100.00% |
| Payout Ratio | -0.69% | -0.96% | -1.04% | -0.53% | 3.19% |